Novo Integrated Sciences
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Cash used in financing activities reached the amount of $763,860 last year. Net change in cash is therefore -$1,762,364.
Cash Flow
| 2015 | -175.62K | -113.87K | 187.91K |
|---|---|---|---|
| 2016 | -109.77K | -462.30K | 150K |
| 2017 | -810.68K | -749.53K | 3.10M |
| 2018 | -934.50K | -217.23K | -11.57K |
| 2019 | -822.26K | -842.91K | 3.07M |
| 2020 | -441.69K | 657.13K | -271.68K |
| 2021 | -1.02M | 2.99M | 4.31M |
| 2022 | -5.88M | 163.45K | -427.11K |
| 2023 | -2.24M | -49.22K | 763.86K |
| 2024 | -2.24M | -49.22K | 763.86K |
NVOS Cash Flow Statement (2015 – 2024)
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 2.17M | 2.17M | 8.29M | 2.06M | 2.08M | 675.70K | 1.89M | 110.31K | 14.12K | 1.83K |
Operating activities | ||||||||||
Net income | -13.26M | -13.26M | -33.04M | -4.47M | -4.92M | -403.57K | -2.11M | -745.26K | -164.88K | -2.77M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 2.30M | 2.30M | 3.01M | 1.72M | 1.44M | 97.14K | 73.44K | 67.77K | 72.58K | 1.01K |
Stock-based compensation expense | 0 | 385.33K | 426.69K | 155.49K | 2.32M | 70.84K | 0 | 252.42K | 50.30K | 327.60K |
| Deferred income tax benefit | 0 | 385.33K | 426.69K | 155.49K | 2.32M | 70.84K | 0 | 252.42K | 50.30K | 327.60K |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -597.19K | -597.19K | 457.00K | 1.10M | -229.01K | -151.25K | -263.15K | -289.31K | 412.21K | -66.54K |
Inventories | -255.78K | -255.78K | -527.39K | -147.81K | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 1.77M | 1.77M | 283.23K | -45.22K | -275.89K | -140.09K | -331.87K | -412.87K | 6.53K | -35.43K |
Cash generated by operating activities | -2.24M | -2.24M | -5.88M | -1.02M | -441.69K | -822.26K | -934.50K | -810.68K | -109.77K | -175.62K |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.10M | 0 | 0 |
Investments In Property Plant And Equipment | -49.22K | -49.22K | -190.16K | -255.94K | -12.11K | -107.63K | -178.62K | -38.23K | -54.98K | -113.87K |
Acquisitions Net | 0 | 0 | 57.48K | 3.72M | -636.98K | -509.35K | 0 | -1.10M | 0 | 0 |
Cash generated by investing activities | -49.22K | -49.22K | 163.45K | 2.99M | 657.13K | -842.91K | -217.23K | -749.53K | -462.30K | -113.87K |
Financing activities | ||||||||||
Common Stock Issued | 480.59K | 1.79M | 0 | 7.32M | 113.39K | 3.25M | 15.56K | 3.38M | 150K | 170K |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | -1.57M | -427.11K | -2.77M | -267.69K | 0 | -6.99K | -131.45K | -64.08K | 17.91K |
Cash used in financing activities | 763.86K | 763.86K | -427.11K | 4.31M | -271.68K | 3.07M | -11.57K | 3.10M | 150K | 187.91K |
Net Change In Cash | -1.76M | -1.76M | -6.11M | 6.22M | -15.94K | 1.40M | -1.22M | 1.78M | 40.22K | 12.29K |
Cash at end of period | 416.32K | 416.32K | 2.17M | 8.29M | 2.06M | 2.08M | 675.70K | 1.89M | 54.35K | 14.12K |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |